Trial Profile
Study of High-dose Olmesartan compared with Telmisartan on Blood pressure and Metabolism in Type 2 Diabetics with Hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Aug 2022
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil (Primary) ; Telmisartan (Primary)
- Indications Hypertension; Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- 05 Aug 2022 Status changed from active, no longer recruiting to completed.
- 27 Jan 2014 Planned End Date changed to 1 Jun 2011 as reported by University Hospital Medical Information Network - Japan record.
- 27 Jan 2014 Status changed from completed to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.